Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
Eastern Cooperative Oncology Group
First Affiliated Hospital of Zhejiang University
Fudan University
Brigham and Women's Hospital
M.D. Anderson Cancer Center
Queensland Centre for Gynaecological Cancer
Mayo Clinic
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Sixth Affiliated Hospital, Sun Yat-sen University
University of Utah
St. Antonius Hospital
University Hospital, Montpellier
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
UNC Lineberger Comprehensive Cancer Center
St. Antonius Hospital
First Affiliated Hospital of Zhejiang University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Radboud University Medical Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Queensland Centre for Gynaecological Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Shanghai Gynecologic Oncology Group
University Hospital, Montpellier
Tianjin Medical University Cancer Institute and Hospital
Fudan University
Fudan University
Qilu Pharmaceutical Co., Ltd.
First Affiliated Hospital of Zhejiang University
First Affiliated Hospital of Zhejiang University
Gaziosmanpasa Research and Education Hospital
The First Affiliated Hospital of Anhui Medical University
Fujian Medical University
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
IRCCS San Raffaele
The First Affiliated Hospital of Air Force Medicial University
Rigshospitalet, Denmark
MegaPro Biomedical Co. Ltd.
Hebei Medical University
Instituto do Cancer do Estado de São Paulo
Hebei Medical University
Sun Yat-sen University